A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Stephen A. Harrison*, Pierre Bedossa, Cynthia D Guy, Jörn M. Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E. Moussa, Guy W. Neff, Mary E. Rinella, Quentin M. Anstee, Manal F. Abdelmalek, Zobair Younossi, Seth Baum, Sven Francque, Michael Charlton, Philip Newsome, Nicolas Lanthier, Ingolf Shiefke, Alessandra MangiaJuan M. Pericas, Rashmee Patil, Arun J. Sanyal, Mazen Noureddin, Meena Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, MAESTRO-NASH Investigators

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences